On October 22, Nobel Prize–winning biochemist Dr. Jennifer Doudna dined with supporters of UCSB Arts & Lectures (A&L) and the Cancer Foundation of S.B. (CFSB). The intimate, al fresco dinner party at ...
Nobel Prize winner Jennifer Doudna, who co-invented CRISPR-Cas9 genome editing technology, joined President Christina Paxson P’19 for a virtual conversation on CRISPR’s wide-ranging applications and ...
UCSB Arts & Lectures and the Cancer Foundation of Santa Barbara co-present Dr. Jennifer Doudna, CRISPR Gene Editing and the Future of Human Health on Tuesday, Oct. 22, at 7:30 p.m. at The Granada ...
Nobel Prize–winning biochemist Dr. Jennifer Doudna is cracking the code of nature to address big issues, using the tiniest parts of us. On Tuesday, UCSB Arts & Lectures and the Cancer Foundation of ...
In a groundbreaking fusion of artificial intelligence and gene editing, researchers are leveraging machine learning to enhance CRISPR technology’s precision and efficiency. This integration is opening ...
Morning Overview on MSN
New CRISPR leap could transform treatment for genetic diseases
Gene editing has moved from theory to bedside with a speed that would have seemed impossible a decade ago. A new wave of ...
CRISPR, or Clustered Regularly Interspaced Short Palindromic Repeats, is an advanced technology developed in 2012 that can be used to edit genes. It can be used to find specific DNA sequences inside ...
The coronavirus disease 2019 (COVID-19) pandemic was one of the most serious public health calamities in the last decade, causing global morbidity and mortality in the millions. The emergence of ...
The global CRISPR technology market is poised for strong expansion, projected to grow at a robust CAGR of approximately 16% over the next five years. This growth is fueled by continuous advancements ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback